AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal
AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest…
11/06/2020 - 3 minutes
AbbVie
AbbVie Enters Industry Collaboration to Fight Alzheimer’s and Parkinson’s Disease
The UK biotech Mission Therapeutics has teamed up with AbbVie to develop new drugs to…
16/11/2018 - 2 minutes
French Biotech Lures Big Pharma with Fibrosis Treatments
This week, Inventiva has received a milestone payment from Boehringer Ingelheim and extended its collaboration with…
05/09/2017 - 1 minute
Next-Gen Cancer Antibody Technology from Germany enters the Clinic
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
13/04/2017 - 2 minutes
Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug
Galapagos has announced to kick off a Phase I trial with its novel Cystic Fibrosis…
23/03/2017 - 2 minutes
Galapagos kicks off a Phase IIa trial for Cystic Fibrosis
After Galapagos and AbbVie expanded their collaboration on cystic fibrosis, Galapagos now announces the start…
02/02/2017 - 2 minutes
World Cancer Day is Saturday! Europe’s Oncology in Numbers
Developments in cancer treatments accelerating, and the market is expanding. Where does Europe stand? Cancer…
02/02/2017 - 4 minutes
One Step Closer to the First Triple Combination Therapy for Cystic Fibrosis
Galapagos and AbbVie are closer to launching a cystic fibrosis treatment that can outperform the…
29/11/2016 - 2 minutes
UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug
Sanofi and Regeneron (NY, US) have ruled their phase III clinical trial immunotherapy Sarilumab a…
31/10/2016 - 3 minutes
New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira
New results from a Phase III trial show that guselkumab, an antibody therapy for the autoimmune…
05/10/2016 - 3 minutes
Galapagos Hangs On: Filgotinib enters Phase III for Rheumatoid Arthritis
After losing AbbVie as a partner, Galapagos has pressed on with Gilead in the development…
25/08/2016 - 2 minutes
Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie
Ablynx has disclosed 'compelling' results for its Phase IIb trial in rheumatoid arthritis. But it…
09/08/2016 - 3 minutes
